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StriatumAltered brain-derived neurotrophic factor (BDNF) signalling and dopaminergic neurotransmission have been
shown in the forebrain in schizophrenia. The ‘two hit’ hypothesis proposes that two major disruptions during
development are involved in the pathophysiology of this illness. We therefore used a ‘two hit’ rat model of com-
bined neonatal and young-adult stress to assess effects on BDNF signalling and dopamine receptor expression.
Wistar rats were exposed to neonatalmaternal separation (MS) stress and/or adolescent/young-adult corticoste-
rone (CORT) treatment. At adulthood the medial prefrontal cortex (mPFC), caudate putamen (CPu) and nucleus
accumbens (NAc)were analysed by qPCR andWestern blot. The ‘two hit’ combination ofMS and CORT treatment
caused signiﬁcant increases in BDNF mRNA and protein levels in the mPFC of male, but not female rats. BDNF
mRNA expression was unchanged in the CPu but was signiﬁcantly reduced by CORT in the NAc. DR3 and DR2
mRNAwere signiﬁcantly up-regulated in themPFC of two-hit rats and a positive correlation was found between
BDNF and DR3 expression in male, but not female rats. DR2 and DR3 expression were signiﬁcantly increased
following CORT treatment in the NAc and a signiﬁcant negative correlation between BDNF and DR3 and DR2
mRNA levels was found. Our data demonstrate male-speciﬁc two-hit effects of developmental stress on BDNF
and DR3 expression in the mPFC. Furthermore, following chronic adolescent CORT treatment, the relationship
between BDNF and dopamine receptor expression was signiﬁcantly altered in the NAc. These results elucidate
the long-term effects of ‘two hit’ developmental stress on behaviour.
© 2014 Published by Elsevier B.V.1. Introduction
Schizophrenia is a severely debilitating neurodevelopmental disorder
which affects approximately 1% of the population and is caused by a
combination of genetic alterations and environmental factors. Meta-
analysis studies have shown a signiﬁcant association between blood
levels of brain-derived neurotrophic factor (BDNF), as well as the
Val66Met polymorphism in the BDNF gene, with schizophrenia [1,2]. In
addition, human post-mortem studies have found signiﬁcantly reduced
mRNA and protein levels of BDNF and its receptor, tropomyosin-related
kinase B (TrkB), in the prefrontal cortex of patients with schizophreniator; DR2, dopamine receptor 2;
x; CPu, caudate putamen; NAc,
eparation
l Science, Faculty of Science,
oora, Victoria 3086, Australia.
an den Buuse).[3,4]. Furthermore, this reduction in BDNFmRNA in the prefrontal cortex
appears to be driven by changes in promoter II-IX of the BDNF gene [5].
BDNFhas a complex genetic structure consisting of eight distinct pro-
moters, each of which contains a 5′ untranslated exon (I–VIII) that is
spliced to one 3′protein coding exon (exon IX), in addition to a transcript
containing a 5′ extended protein coding exon (IXa) [6]. These exon-
speciﬁc promoters are region-speciﬁc and serve a number of functions:
they can differentially regulate local BDNF expression within somatic
and dendritic compartments [7]; they contain different elements, such
as cAMP response element (CRE) for the CRE-binding protein (CREB)
transcription factor and estrogen response elements (ERE), which
allow for additional regulation of BDNF transcription [8–11], and they
are differentially responsive to environmental stress [12–14]. Remark-
ably, all of the above mentioned exon-speciﬁc promoters transcribe a
single precursor preproBDNF (32 kDa), which is then cleaved to a
minor truncated protein (proBDNF, 28 kDa) and mature BDNF
(mBDNF, 13.5 kDa) [15]. The mature BDNF isoform exerts the majority
of its effects through TrkB, triggering a number of intracellular signalling
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tein kinase (MEK-MAPK), phosphatidylinositol-3-kinase (PI-3-K), and
phospholipase C-γ (PLC-γ) [16].
Excessive dopaminergic neurotransmission has been associated
with the psychotic symptoms of schizophrenia and dopamine receptor
(DR) antagonism is the core mechanism of action of most antipsychotic
drugs [17–19]. BDNF released fromdopamine neurons is responsible for
the induction of DR3 expression in the nucleus accumbens in develop-
ment and adulthood [20]. Conversely, DR1- and DR2-mediated activa-
tion of calcium signalling cascades has been shown to increase striatal
BDNF expression [21] and chronic treatment with antipsychotic drugs
has been shown to reduce BDNF expression in rats [22,23]. Hence, a
strong relationship appears to exist between BDNF and DA signalling.
The ‘two hit’ hypothesis suggests that schizophrenia is caused by a
combination of disruptions during speciﬁc periods of development.
The ﬁrst ‘hit’ occurs during the perinatal period and causes increased
vulnerability of the brain to a second ‘hit’ during the adolescent/
young-adult period,whichmay then trigger disease onset [24]. However,
the effect of such ‘hits’ on BDNF signalling and dopamine neurotrans-
mission remains unclear. Previous studies have shown that neonatal
maternal separation (MS) in rats induced disruptions in prepulse inhi-
bition [25,26] and long-term cognitive impairments [27]. BDNF expres-
sion following MS appears to be time-dependent, with the immediate
effects being an up-regulation of BDNF mRNA in hippocampal and
cortical regions [27,28], while long-term effects of MS lead to a reduc-
tion in hippocampal BDNF mRNA expression [27]. In addition, chronic
treatment with the stress hormone, corticosterone (CORT), has been
shown to induce disruptions to cortical and prefrontal BDNF mRNA
and protein [29,30]. Local infusion of CORT in the prefrontal cortex
increases dopamine efﬂux [31], while chronic (2 weeks) CORT treat-
ment causes a reduction in DR2 receptormRNA expression in the dorsal
striatum of rats [32]. We have modelled the ‘two hit’ scenario in rats by
a combination of MS and chronic treatment with CORT. Our previous
studies demonstrated deﬁcits in spatial memory, reduced mRNA
expression of BDNF in the hippocampus [33], and an inhibitory effect
of the two ‘hits’ on dopaminergic regulation of prepulse inhibition
[34]. The observations of a spatial memory deﬁcit were recently
conﬁrmed and expanded in a separate cohort, whereby we found that
the Y-maze deﬁcit in ‘two hit’ rats was speciﬁc to males, and further,
that female, but notmale ‘twohit’ rats, displayed an anhedonic phenotype
[35]. These behavioural phenotypes were accompanied by male-speciﬁc
and female-speciﬁc reductions in mature BDNF protein expression in
the dorsal and ventral hippocampus, respectively [35], thus suggesting
that MS and chronic adolescent CORT can cause long-term effects on
BDNF expression and that this may regulate adult behaviour. However,
it is unclear how these stressors impact on forebrain regions implicated
in schizophrenia, such as the prefrontal cortex and striatum.
Previous studies have shown reduced mRNA expression of BDNF
and its receptor TrkB in the prefrontal cortex of schizophrenia patients
[36]. In addition, signiﬁcant alterations in the mRNA expression of
DR1 and DR2 have been shown in the dorsolateral prefrontal cortex of
schizophrenia patients compared to controls [37]. Alterations in striatal
DR2 density remain a consistent ﬁnding in schizophrenia [38]. Further-
more, alterations in D2/D3 mRNA expression have been shown in the
nucleus accumbens of a methylazoxymethanol acetate (MAM)-treated
rat model of schizophrenia [39], and antipsychotics such as haloperidol
and clozapine alter DR2 and DR3 expression in the NAc of a genetic rat
model of schizophrenia [40].
In the current studywe sought to determine the long-term effects of
MS and chronic CORT treatment, either individually or combined, on
BDNF expression in discrete regions of the rat forebrain, including the
medial prefrontal cortex (MPFC), caudate putamen (CPu) and nucleus
accumbens (NAc). In order to gain a complete understanding of BDNF
expression and signalling, we measured exon-speciﬁc BDNF mRNA as
well as mature BDNF protein levels. Furthermore, we analysed expres-
sion of dopamine DR2 and DR3 receptors to determine whetherneurodevelopmental stressors at two different time points might
impact on long term dopamine neurotransmission.
2. Methods
1. Animals and treatment paradigms
Weused outbredWistar ratswhichwere obtained fromMonashUni-
versity (Clayton, VIC, Australia). Pregnant female rats were individually
housed and checked twice daily for newborn litters. Within 24 h after
birth, litters were culled to a maximum of eight pups, with equal sex
ratio where possible. From postnatal day (pnd) 2 until pnd 14, pups
were separated for a period of 3 h every day, from 09:00 to 12:00.
While the dam was removed from the pups and placed into a new
clean cage, the litter remained in the home cage but was transferred to
a different room where they were out of sight, smell and hearing
distance of the mother. The cage with pups was placed on a heat pad
(approximately 30 °C) to maintain body temperature. Control, non-
separated (NS) rats underwent 10–15 s of brief separation.
CORT (Sigma-Aldrich, St. Louis, MI, USA) treatment was delivered in
the drinking water for 3 weeks from 8, 9 and 10 weeks of age. To this
end, CORT was dissolved in a minimal amount of 100% ethanol and di-
luted to 50 mg/L with tap water (end concentration 0.5–1.0% ethanol).
Control rats received the vehicle (veh) solution (0.5% ethanol in tap
water).
Using only up to 2 pups/sex/treatment group from each litter, there
were four treatment groups for each sex: NS/veh (males n=9; females
n=11), MS/veh (males n=11; females n=13), NS/CORT (males n=
11; females n=11) andMS/CORT (males n=12; females n=11). An-
imals were sacriﬁced at 16 weeks of age (6 weeks after ﬁnishing CORT
treatment). Five - seven animals per group/sex were used for Western
blot analysis, while 5–6 animals per group/sex were used for mRNA
analysis. All procedures and experiments were approved by the Animal
Experimentation Ethics Committee of the Florey Institute for Neurosci-
ence and Mental Health, University of Melbourne.
2. Dissection of brains
Using razor blades and a stainless steel rat brain slice matrix with
1.0 mm coronal slice intervals, two 2 mm thick coronal slices were ob-
tained (coronal section 1 (Fig. 1A): approximately bregma 4.70–2.70,
coronal section 2 (Fig. 1B): approximately bregma 2.70–0.70) [41].
Slices were immediately removed from the matrix and submerged in
the RNA stabilisation solution, RNAlater (Life Technologies, USA).
Using a scalpel and ﬁne curved forceps, three areas of interest were dis-
sected from the slices: the MPFC was dissected from coronal section 1
(Fig. 1A), whereas the CPu and NAc (ventral striatum) were dissected
from coronal section 2 (Fig. 1B). The MPFC contained the prelimbic
(PrL), infralimbic (IL), cingulate (Cg1) and secondary motor cortex
(M2). The NAc contained the accumbens shell (AcbSh), the lateral
accumbens shell (LAcbSh) and the accumbens core (AcbC) [41]. Care
was taken not to include cortical tissue in the CPu sample.
3. Protein extraction, Western blot, RNA extraction and qPCR
Details of protein extraction and Western blot are provided in [35].
Reagents included radio-immunoprecipitation assay (RIPA) lysis buffer
containing 150 mM sodium chloride (ChemSupply, AU), 1.0% Triton-X-
100 (SigmaAldrich), 0.1% sodiumdodecyl sulphate (Sigma Aldrich) and
50 mM Tris pH 8.0 (Trizma Base, Sigma Aldrich), as well as protease
inhibitor cocktail set III (1:200, Merck, Kilsyth, VIC, Australia) and set
IV (1:50, Merck). Protein concentrations were determined using the
bicinchoninic acid (BCA) protein assay kit (Thermo Scientiﬁc, Rockford,
IL, USA).
For Western blot analysis [35], 50 μg of protein was added with
loading buffer (0.4 M Tris pH 6.8, 37.5% glycerol, 10% SDS, 1% 2
Fig. 1. Representative coronal sections of 2 mm slices taken from the forebrain, adapted from Paxinos andWatson 2005. (A) The mPFC (shaded in), which contained the prelimbic (PrL),
infralimbic (IL), cingulate (Cg1) and secondary motor cortex (M2), was dissected from slice 1, approximately bregma 4.70–2.70. (B) The CPu and NAc (shaded in), which contained the
accumbens shell (AcbSh), the lateral accumbens shell (LAcbSh) and the accumbens core (AcbC), were dissected from slice 2, approximately bregma 2.70–0.70.
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tured (10 min) at 95 °C before SDS-PAGE (15% or 10% acrylamide gel,
120 V, 1.5 h). After transfer to a nitrocellulose membrane, primary anti-
body incubation was done overnight at 4 °C. Primary antibodies were
rabbit anti-BDNF (H-117, 1:200, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), rabbit anti-proBDNF (ab108383, 1:2000, Abcam, Cambridge,
UK), rabbit anti-Phospho TrkB (1:1000, Signalway, College Park, MD,
USA), rabbit anti-TrkB (1:1000, Santa Cruz Biotechnology) and mouse
anti-β-actin (42 kDa; 1:10000, Sigma-Aldrich). The next day, anti-rabbit
or anti-mouse IgG HRP-linked secondary antibodies (Cell Signalling,
Danvers, MA, USA) were applied and images were captured using a
Luminescence Image Analyzer (Fujiﬁlm LAS-4000, FujiFilm Life Science,
Stamford, CT, USA). Multi Gauge software (FujiFilm Life Science) was
used to quantify data for protein levels which were normalised against
levels of β-actin and expressed relative to the average value of themale
control group (NS/veh).
As described in detail previously [35], RNA was extracted using Trizol
(SigmaAldrich). RNAwas incubatedwith DNase (1 μl/10mgRNA, Roche,
Indianapolis, IN,USA) for 3h at 37 °C andpuriﬁedwith anRNeasyMini Kit
(Qiagen, Germantown, MD, USA). cDNA was prepared from RNA using
Taqman Reverse Transcription reagents (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer's instructions.
Primerswere designed using Primer Express 3.0 (Applied Biosystems)
(see [35]). For qPCR analysis, an EpMotion liquid handling robot
(Eppendorf, North Ryde, NSW, Australia) and MicroAmp 384-well plates
were used, with added SYBR GreenMastermix (Applied Biosystems). The
384-well plates were run on a Viia 7 real-time PCR system (Applied
Biosystems) and gene expression was compared with 18 s according to
the formula RT = 2−ΔΔCt [42]. Data are expressed relative to the average
value of the male control group (NS/veh).
4. Statistical analysis
ANOVA was used to determine statistically relevant changes be-
tween treatment groups for each sex, brain region and exon separately,the factors being MS, CORT treatment and sex (SYSTAT 13, Chicago, IL,
USA). A p-value of less than 0.05 was considered statistically signiﬁcant.
3. Results
1. BDNF, TrkB and dopamine receptor expression in the mPFC
ANOVA revealed a signiﬁcant MS × CORT × sex interaction
(F(1,38) = 9.6, P = 0.004) in the expression of protein-coding BDNF
exon IXmRNA in themPFCwithmale ‘two hit’ rats showing signiﬁcant-
ly increased expression compared to all other groups (Fig. 2A). In
addition, a signiﬁcant sex × MS effect was found for proBDNF protein
expression (F(1,42) = 8.8, P = 0.005) with the male two-hit group
showing the highest expression levels (Fig. 2B). A similar MS × CORT ×
sex interactive effect was found for mature BDNF protein levels
(F(1,45) = 5.1, P= 0.028) with two-hit males showing increased levels
compared to all other groups (Fig. 2C). The selective ‘two hit’ up-
regulation after combined MS and CORT was not observed for any of
the other, non-coding exons (Table 1). Instead, there were several
other effects including markedly increased expression of BDNF exon I
mRNA after MS (F(1,37) = 22.8, P b 0.001) but decreased expression of
exon VII and VIII in males only (F(1,38) = 13.7, P= 0.005) (Table 1).
No signiﬁcant changes were found in full-length TrkB protein
expression (Fig. 2D); however, females showed signiﬁcantly lower
phosphorylated TrkB protein expression than males (main effect of
sex: F(1,40) = 5.55, P= 0.023) (Fig. 2E).
A signiﬁcant effect ofMS (F(1,32)=6.3, P= 0.017) and a signiﬁcant
MS × CORT × sex interaction (F(1,32)= 5.3, P= 0.028) were found for
DR3 mRNA expression in the MPFC, with male ‘two hit’ rats showing
signiﬁcantly increased expression compared to all other groups
(Fig. 2F). A signiﬁcant effect of CORT (F(1,35) = 7.5, P = 0.01), MS
(F(1,35) = 7.9, P = 0.008) and sex (F(1,35) = 10.9, P = 0.002) was
found onDR2mRNAexpression in theMPFC (Fig. 2G). In addition, a sig-
niﬁcant CORT × sex interaction was found (F(1,35) = 0.11, P =0.04).
We then analysed males and females separately and found that CORT
Fig. 2. BDNF-TrkB expression and signalling and dopamine receptor expression in the mPFC. (A) BDNF mRNA levels, (B) ProBDNF protein levels, (C) Mature BDNF protein levels, (D) Full-
length TrkB protein expression, (E) Phosphorylated TrkB / full-length TrkB protein levels, (F) DR3 mRNA levels and (G) DR2 mRNA levels. ND/veh = non-deprived/vehicle-treated, ND/
CORT = non-deprived/corticosterone-treated, MS/veh = maternally-deprived/vehicle-treated andMS/CORT =maternally-deprived/corticosterone-treated. * = signiﬁcant MS × CORT ×
sex interaction P b 0.05, # over a horizontal line with vertical bars at either end = signiﬁcant effects of CORT treatment, $ over a horizontal line = signiﬁcant effects of MS, */#/$ =
P b 0.05. n= 5–6/group.
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P= 0.03), but not females, whereas MS signiﬁcantly increased DR2 ex-
pression in females (F(1,20) = 7.9, P= 0.01), but not males.
The expression pattern of DR3 mRNA was similar to that of
BDNFmRNA expression and linear regression analysis revealed a signif-
icant positive correlation between DR3 and BDNF mRNA expression
(Fig. 3A; r2 = 0.33, P b 0.001) in the mPFC. In contrast, DR2 expression
did not correlate signiﬁcantly with BDNF mRNA expression (Fig. 3B).
However, DR2 expression did correlate signiﬁcantly with both proBDNF
(Fig. 3D; P= 0.0003, r2 = 0.28) and mature BDNF (Fig. 3F; P= 0.001,
r2 = 0.24) protein expression, while no correlations were found
between BDNF protein expression and DR3 (Fig. 3C and D).Table 1
Exon-speciﬁc BDNF transcript expression in the medial prefrontal cortex of male and female r
male control group ± SEM.
Fold-change from male controls
Transcript Males Females
CORT MS MS+CORT Control CORT M
BDNF exon I 0.85 ± 0.13 1.46 ± 0.30 1.48 ± 0.21 1.20 ± 0.15 1.15 ± 0.23 1
BDNF exon II 0.72 ± 0.06 0.92 ± 0.16 0.94 ± 0.11 0.91 ± 0.06 0.82 ± 0.09 1
BDNF exon III 0.94 ± 0.09 0.92 ± 0.09 0.78 ± 0.06 0.77 ± 0.33 0.70 ± 0.06 1
BDNF exon IV 0.92 ± 0.12 0.93 ± 0.15 1.05 ± 0.12 0.73 ± 0.04 0.77 ± 0.08 1
BDNF exon VI 0.83 ± 0.14 0.87 ± 0.15 0.96 ± 0.11 0.72 ± 0.07 0.62 ± 0.09 1
BDNF exon VII 0.99 ± 0.16 0.54 ± 0.14 0.65 ± 0.08 0.80 ± 0.11 0.57 ± 0.08 0
BDNF exon VIII 0.85 ± 0.09 0.44 ± 0.10 0.68 ± 0.05 0.64 ± 0.40 0.52 ± 0.10 0
BDNF exon IXa 1.22 ± 0.14 0.76 ± 0.22 0.84 ± 0.04 0.81 ± 0.13 0.67 ± 0.15
BDNF exon IX 0.95 ± 0.03 0.93 ± 0.08 1.46 ± 0.13 0.95 ± 0.08 0.92 ± 0.09 1
MS=maternal separation, CORT = corticosterone treatment; ↑ indicates main effect as analy2. BDNF, TrkB and dopamine receptor expression in the caudate putamen
Expression levels of BDNF in the CPu were low and variable (Fig. 4).
A signiﬁcant sex × CORT interaction was found in themRNA expression
of BDNF exons I (F(1,38) = 4.3, P= 0.04), II (F(1,38) = 4.1, P= 0.04)
and IXa (F(1,39)=4.1, P= 0.04), with females, but notmales, showing
an up-regulation following CORT treatment (Table 2). In addition, a sig-
niﬁcant MS × CORT interaction was found for exon I (F(1,38) = 7.6,
P = 0.009) (Table 2). However, despite these exon-speciﬁc changes,
total protein coding exon IX levels were unchanged in the CPu in all
groups analysed (Fig. 4A). Females showed higher proBDNF (F(1,48) =
18.7, P b 0.001) and mature BDNF (F(1,45) = 15.1, P b 0.001) proteinats. Data represent mean percentage fold-change from the non-separated/vehicle-treated
S MS+CORT Effect
.86 ± 0.27 1.70 ± 0.13 ↑MS, P b 0.0001
.18 ± 0.14 1.03 ± 0.05 ↑MS, P = 0.049
.03 ± 0.06 0.79 ± 0.04 ↓CORT, P = 0.018; MS × sex, P = 0.007
.10 ± 0.09 0.91 ± 0.06 0
.04 ± 0.15 0.78 ± 0.07 0
.95 ± 0.16 0.60 ± 0.06 MS × sex, P = 0.005
.80 ± 0.11 0.54 ± 0.02 ↓MS, P = 0.02; MS × sex, P = 0.001; MS × CORT × sex,
P = 0.036
1.0 ± 0.16 0.73 ± 0.02 MS × sex, P = 0.031
.33 ± 0.15 1.06 ± 0.04 ↑MS, P = 0.002; CORT × sex, P = 0.009; MS × CORT × sex,
P = 0.004
sed by ANOVA.
Fig. 3. Linear regression graphs showing correlation analysis of (A) BDNF mRNA (x axis)
and DR3 mRNA (y axis) in the mPFC, (B) BDNF mRNA (x axis) and DR2 mRNA (y axis)
levels in the mPFc, (C) proBDNF protein (x axis) and DR3 mRNA (y axis) levels in the
MPFC, (D) proBDNF protein (x axis) and DR2 mRNA (y axis) levels in the MPFC, (E)
mBDNF protein (x axis) and DR3 mRNA (y axis) levels in the MPFC, (F) mBDNF protein
(x axis) and DR2 mRNA (y axis) levels in the MPFC.
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(Fig. 4B and C).
Analysis of TrkB protein levels in the CPu revealed a signiﬁcant
MS × CORT interaction (F(1,48) = 7.6, P = 0.008) and a signiﬁcant
effect of sex (F(1,48) = 4.12, P = 0.048) with male ‘two hit’ rats
showing a signiﬁcant increase in full-length TrkB protein expression
(Fig. 4D). However, a signiﬁcant effect of sex (F(1,45) = 9.1, P =
0.004), an MS × CORT interaction (F(1,45) = 5.1, P = 0.03) and a
sex × CORT interaction (F(1,45) = 6.2, P = 0.016) reﬂected that
TrkB phosphorylation (pTrkB/TrkB) was reduced in male ‘two hit’
rats only (Fig. 4E).
Male rats showed higher expression than females of DR3
(F(1,36) = 14.5, P = 0.001) and DR2 (F(1,39) = 6.3, P = 0.015)
mRNA in the CPu; however, no further group differences were found
(Fig. 4F and G). No signiﬁcant correlations were found between BDNF
mRNA and DR2 or DR3 mRNA expression, BDNF protein and DR2 orDR3 mRNA, or TrkB expression or phosphorylation and DR2 or DR3
mRNA expression in the CPu (data not shown).
3. BDNF, TrkB, and dopamine receptor expression in the NAc
Total, protein coding BDNF exon IX expression was signiﬁcantly re-
duced following CORT treatment in the NAc (Fig. 5A; F(1,36) = 6.0,
P = 0.019) and, in addition, females showed higher expression levels
than males (F(1,36) = 4.1, P = 0.049). These effects of CORT and sex
on exon IX expression appeared to be driven by similar alterations in
exon III (main effect of CORT: F(1,37) = 4.3, P= 0.045; main effect of
sex: F(1,37) = 6.7, P = 0.013), exon IV (CORT: F(1,35) = 4.4, P =
0.043; sex: F(1,35) = 4.8, P = 0.035) and exon IXa (sex: F(1,36) =
4.6, P = 0.038) (Table 3). A signiﬁcant effect of sex (F(1,45) = 29.5,
P b 0.001) was found for proBDNF protein expression with females
showing higher expression overall; however, no further group differ-
ences were found here (Fig. 5B). A trend for a CORT × sex interaction
was found for mature BDNF protein expression (Fig. 5C; F(1,42) = 3.8,
P = 0.056) with males, but not females showing reduced expression
following CORT treatment.
With respect to TrkB protein expression, a signiﬁcant effect of sex
(F(1,47) = 74.1, P b 0.001) and a signiﬁcant effect of MS (F(1,47) =
8.93, P= 0.004) were found, with MS causing an increase and females
showing higher levels overall (Fig. 5D). A signiﬁcant effect of sex
(F(1,47) = 49.8, P b 0.001) and a signiﬁcant effect of CORT (F(1,47) =
8.98, P= 0.004) were found on phosphorylated TrkB (pTrkB/TrkB) ex-
pression with reduced expression following CORT treatment and lower
overall expression levels found in females (Fig. 5E).
Analysis of DR3 mRNA expression in the NAc showed a signiﬁcant
effect of CORT (F(1,39) = 4.5, P = 0.04), sex (F(1,39) = 14.7,
P b 0.001) and a CORT × sex interaction (F(1,39) = 4.7, P = 0.037),
with males but not females showing a marked and signiﬁcant increase
following CORT treatment (Fig. 5F). No signiﬁcant effect of treatment
or sex was found on DR2 receptor mRNA expression (Fig. 5G). Correla-
tion analysis showed a signiﬁcant negative correlation between BDNF
exon IX mRNA expression and DR3 mRNA expression (Fig. 6A, r2 =
0.23, P = 0.002) and DR2 mRNA expression (Fig. 6B, r2 = 0.29, P =
0.0002) in the NAc. In addition, amodest, but signiﬁcant negative corre-
lation was also found between phosphorylated TrkB protein expression
and DR3 mRNA expression in this brain region in males only (Fig. 6C,
r2 = 0.29, P= 0.01).
4. Discussion
We examined the long-term effects of early postnatal stress in the
form of MS, adolescent/young-adult stress in the form of chronic CORT
treatment, and the combined effect of the two stressors on BDNF signal-
ling as well as DR2 and DR3 mRNA expression in discrete forebrain re-
gions. In the MPFC of adult male rats, signiﬁcant increases in BDNF
mRNA and protein levels, as well as DR3 expression were observed fol-
lowing the ‘two hit’ combination of neonatal and adolescent/young-
adult stress. This was not observed in female rats. Male-speciﬁc, ‘two
hit’ effects were also evident in the CPu, with alterations in TrkB protein
expression and phosphorylation that may reﬂect a disruption in the
anterograde transport of BDNF from the MPFC to the CPu. BDNF mRNA
expression was signiﬁcantly reduced by CORT treatment in the NAc;
however, both DR3 and DR2 were signiﬁcantly up-regulated following
CORT treatment and a negative correlation between BDNF mRNA and
DR3 and DR2 mRNA was found in the NAc.
In addition to region- and sex-speciﬁc effects of MS and CORT on
BDNF exon IX expression and protein levels, we found several BDNF
exon-speciﬁc effects. For example, in the mPFC, MS signiﬁcantly
increased expression of exons I and II. Thus, effects on BDNF exon IX
expression and protein levels were associated with a number of differ-
ential exon-speciﬁc changes depending on the region investigated or
sex of the animals. This may represent alternate mechanisms which
Fig. 4. BDNF-TrkB expression and signalling and dopamine receptor expression in the CPu. (A) BDNFmRNA levels, (B) Pro BDNF protein levels, (C)Mature BDNF protein levels, (D) Full-length
TrkB protein levels, (E) Phosphorylated TrkB / full-length TrkB protein levels, (F) DR3mRNA levels, (G) DR2mRNA levels. ND/veh=non-deprived/vehicle-treated, ND/CORT=non-deprived/
corticosterone-treated, MS/veh= maternally-deprived/vehicle-treated andMS/CORT=maternally-deprived/corticosterone-treated. n= 5–6/group. *= signiﬁcantMS × CORT × sex inter-
action P b 0.05.
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between the sexes. In contrast to previous studies [43], protein levels
of BDNF in the current study were dissimilar to exon IV expression,
but did parallel expression of protein-coding exon IX expression.
There were also several effects whichwere unique to MS or to CORT
treatment, without ‘two hit’ interactions. Previous reports on the imme-
diate effects ofMS stress in the form ofmotherless rearing showed a de-
crease in prefrontal cortex BDNF protein expression [44], while adult
stress in the form of 2 days of forced-swim stress caused an immediate
increase in BDNF protein levels in the ventral OFC of adult rats [45].
Chronic stress in the adult rat has been shown previously to cause an
immediate increase in BDNF mRNA levels in the prefrontal cortex [46,
47]. Furthermore, 3 weeks of CORT treatment in rats causes an immedi-
ate decrease speciﬁcally in exons II and IV transcripts in the frontal
cortex and hippocampus [14]. Overall, it would appear that the timing
of the stressors is an important factor in the resulting changes in BDNFTable 2
Exon-speciﬁc BDNF transcript expression in the dorsal caudate nucleus/putamen of male and f
treated male control group ± SEM.
Fold-change from male controls
Transcript Males Females
CORT MS MS+CORT Control CORT
BDNF exon I 0.29 ± 0.12 0.26 ± .11 0.48 ± 0.16 0.42 ± 0.18 0.47 ± 0
BDNF exon II 0.41 ± 0.16 0.31 ± 0.13 0.44 ± 0.15 0.38 ± 0.16 0.53 ± 0
BDNF exon III 0.43 ± 0.18 0.38 ± 0.17 0.48 ± 0.19 0.33 ± 0.16 0.57 ± 0
BDNF exon IV 0.50 ± 0.21 0.32 ± 0.15 0.54 ± 0.20 0.35 ± 0.16 0.71 ± 0
BDNF exon VI 0.41 ± 0.18 0.31 ± 0.15 0.43 ± 0.16 0.34 ± 0.14 0.64 ± 0
BDNF exon VII 0.55 ± 0.28 0.73 ± 0.32 0.47 ± 0.32 0.31 ± 0.14 0.55 ± 0
BDNF exon VIII 0.67 ± 0.35 0.69 ± 0.32 0.49 ± 0.20 0.35 ± 0.16 0.67 ± 0
BDNF exon IXa 0.61 ± 0.29 0.74 ± 0.34 0.42 ± 0.17 0.25 ± 0.11 0.66 ± 0
BDNF exon IX 0.40 ± 0.16 0.39 ± 0.13 0.44 ± 0.16 0.36 ± 0.17 0.58 ± 0
MS=maternal separation, CORT = corticosterone treatment; ↑ indicates main effect as analyexpression. For example, total BDNF mRNA levels measured 0, 2, 24
and 72 h after foot shock stress was increased in the prelimbic and
infralimbic mPFC at 0 and 2 h post-stress, but unchanged at 24 or 72 h
[48]. In addition, in the human prefrontal cortex exon-speciﬁc expres-
sion of BDNF has been shown to change signiﬁcantly throughout devel-
opment, with protein expression following a similar pattern to exon IV
expression [43]. Thismay suggest that alternative promoters are used to
drive BDNF expression in a time-dependent manner, and therefore
applying a particular stressor at a speciﬁc period of development will
have differential effects on the various promoter-speciﬁc exons.
Different types of stress paradigms applied may also elicit differen-
tial effects on BDNF expression. For example, chronic restraint stress
during adulthood led to an immediate decrease, while repeated injec-
tions of the corticotrophin-releasing factor receptor agonist, urocortin,
to the basolateral amygdala in adulthood actually increased BDNF
protein expression in the prefrontal cortex [49]. Furthermore, predatoremale rats. Data represent mean percentage fold-change from the non-separated/vehicle-
MS MS+CORT Effect
.21 0.27 ± 0.13 0.70 ± 0.21 ↑MS × CORT P = 0.009, sex × CORT, P = 0.04
.23 0.25 ± 0.13 0.55 ± 0.15 CORT × sex, P = 0.049
.29 0.26 ± 0.15 0.58 ± 0.16 0
.47 0.28 ± 0.17 0.62 ± 0.18 0
.10 0.24 ± 0.15 0.47 ± 0.13 0
.29 0.25 ± 0.12 0.43 ± 0.13 0
.34 0.21 ± 0.11 0.39 ± 0.12 0
.34 0.22 ± 0.12 0.38 ± 0.10 CORT × sex, P = 0.049
.30 0.30 ± 0.17 0.59 ± 0.18 0
sed by ANOVA.
Fig. 5. BDNF-TrkB expression and signalling and dopamine receptor expression in the NAc. (A) BDNF mRNA levels, (B) proBDNF protein levels, (C) Mature BDNF protein levels, (D) Full-
length TrkB protein levels, (E) Phosphorylated TrkB / full-length TrkB protein levels, (F) DR3 mRNA levels, (G) DR2 mRNA levels. ND/veh = non-deprived/vehicle-treated, ND/CORT =
non-deprived/corticosterone-treated,MS/veh= maternally-deprived/vehicle-treated, andMS/CORT=maternally-deprived/corticosterone-treated. # over a horizontal linewith vertical
bars at either end = signiﬁcant effects of CORT treatment, $ over a horizontal line = signiﬁcant effects of MS, */#/$ = P b 0.05. ^ = P b 0.1, n= 5–6/group.
2132 R.A. Hill et al. / Biochimica et Biophysica Acta 1842 (2014) 2126–2135exposure stress had no immediate effect onMPFC BDNF protein expres-
sion in adult rats [50].
The observation, that the combined effect of two ‘hits’ on BDNF
mRNA and protein in the mPFC was speciﬁc to males, may suggest a
role for sex steroids hormones, such as testosterone or estrogen, in
modulating this stress response. Indeed, the BDNF gene does contain a
sequence with close homology to the estrogen response element
(ERE) in its protein coding region, and BDNF and estrogen share
converging downstream signalling pathways [51]. In addition to the
male-speciﬁc ‘two hit’ effect on BDNF, we found a similar increase in
DR3 expression and a signiﬁcant, positive correlation between BDNF
mRNA and DR3mRNA expression. This is consistent with the literature;
an acute exposure to cocaine produced a long-lasting increase in total
BDNF mRNA and DR3 expression in the prefrontal cortex of rats [52]Table 3
Exon-speciﬁc BDNF transcript expression in the nucleus accumbens of male and female rats. D
control group ± SEM.
Fold-change from male controls
Transcript Males Females
CORT MS MS+CORT Control
BDNF exon I 1.26 ± 0.53 3.7 ± 1.2 0.96 ± 0.44 3.6 ± 2.3
BDNF exon II 1.0 ± 0.28 1.4 ± 0.41 0.59 ± 0.04 2.8 ± 0.87
BDNF exon III 1.1 ± 0.33 1.9 ± 0.56 0.61 ± 0.12 4.2 ± 1.33
BDNF exon IV 0.99 ± 0.36 1.9 ± 0.73 0.46 ± 0.13 4.2 ± 1.46
BDNF exon VI 1.2 ± 0.42 1.7 ± 0.61 0.43 ± 0.11 3.1 ± 1.00
BDNF exon VII 1.2 ± 0.47 1.5 ± 0.65 0.25 ± 0.07 2.8 ± 0.90
BDNF exon VIII 1.2 ± 0.51 1.2 ± 0.53 0.23 ± 0.06 2.4 ± 0.85
BDNF exon IXa 0.90 ± 0.29 0.68 ± 0.32 0.31 ± 0.08 2.3 ± 0.78
BDNF exon IX 1.2 ± 0.40 2.3 ± 0.68 0.63 ± 0.19 3.9 ± 1.15
MS=maternal separation, CORT = corticosterone treatment; ↑ indicates main effect as analyand a recent report demonstrated a similar positive correlation between
BDNF protein and mRNA and DR3 mRNA levels in the prefrontal cortex
of rats at 20, 35, 40 and 60 days of age [53]. Furthermore, Andersen et al.
also showed that treatmentwith the DR3-preferring agonist, 7-OHDPAT,
increased BDNFmRNA levels in the prefrontal cortex, suggesting that al-
terations in DR3may be driving changes in BDNF expression [53]. Given
the lack of change in TrkB expression and phosphorylation in the mPFC
we would also propose, as above, that it is DR3 that may be driving
changes in BDNF expression. Deletion of the DR3 receptor has been
shown to increase levels of the tissue plasminogen activator (tPA), the
enzyme responsible for cleavage of pro-BDNF to mature BDNF, in the
prefrontal cortex of mice, and consequently leads to alterations in total
BDNF mRNA and protein levels [54]. This may represent a mechanism
by which alterations to DR3 lead to alterations in BDNF expression.ata represent mean percentage fold-change from the non-separated/vehicle-treated male
CORT MS MS+CORT Effect
1.2 ± 0.60 1.9 ± 0.47 4.6 ± 1.6 ↑MS, P = 0.04
0.89 ± 0.20 1.3 ± 0.22 1.60 ± 0.5 0
1.1 ± 0.40 2.4 ± 0.56 2.6 ± 0.94 Sex, P = 0.013/CORT, P = 0.045
1.4 ± 0.52 2.6 ± 0.68 3.1 ± 1.1 Sex, P = 0.035/CORT, P = 0.043
1.2 ± 0.44 2.6 ± 0.69 2.2 ± 0.73 0
0.82 ± 0.33 1.9 ± 0.51 2.0 ± 0.68 0
0.73 ± 0.26 1.5 ± 0.40 1.6 ± 0.56 0
0.84 ± 0.31 1.8 ± 0.48 1.6 ± 0.54 Sex, P = 0.038
1.6 ± 0.48 3.2 ± 0.98 2.40 ± 1.15 Sex, P = 0.049/CORT, P = 0.019
sed by ANOVA.
Fig. 6. Linear regression graphs showing correlation analysis of (A) BDNFmRNA (x axis) and DR3mRNA (y axis) in the NAc, (B) BDNFmRNA (x axis) and DR2mRNA (y axis) levels in the
NAc and (C) TrkB phosphorylation/full-length TrkB (x axis) and DR3 (y axis) expression in the NAc.
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pression and BDNF mRNA expression, we did ﬁnd a signiﬁcant positive
correlation between protein expression of both pro- and mature BDNF
and DR2 in themPFC. Previous reports have shown that blockade of do-
pamine receptors (predominantly DR2) via 3 days of treatment with
haloperidol down-regulates BDNF protein expression in the prefrontal
cortex, conﬁrming a positive correlation between DR2 activation and
BDNF expression [55].
Male-speciﬁc ‘two hit’ effects were also noted in the CPu, where al-
though BDNF mRNA and protein levels were unchanged, TrkB expres-
sion was increased and TrkB phosphorylation was decreased. This may
be a compensatory response to the increased BDNF protein expression
in the mPFC. Indeed, we previously demonstrated an inverse relation-
ship between mature BDNF protein levels and TrkB protein phosphory-
lation in the striatum of BDNF heterozygous mice whereby mature
BDNF levels were reduced, but TrkB phosphorylation was increased
[56]. Levels of BDNF mRNA have previously been reported to be low in
the CPu; however, this region receives extensive projections from corti-
cal pyramidal neurons that can anterogradely transport mature BDNF
protein [57]. In addition, region-speciﬁc knockdown of BDNF in the
prelimbic, but not orbitofrontal cortex, caused a reduction in striatal
BDNF protein expression [58]. TrkB is abundantly expressed in the
CPu [59], and we suggest that alterations to TrkB expression and
phosphorylation in the CPu of male ‘two hit’ rats are due to increased
anterograde transport of BDNF from the mPFC.
In the NAc region, CORT treatment reduced BDNF mRNA but
increased DR3 expression, leading to a signiﬁcant negative correlation
between BDNF and DR3 expression. A negative correlation was also
shown between TrkB phosphorylation and DR3 expression in males
only. This ﬁnding was unexpected as earlier reports suggest that BDNF
drives DR3 expression in the NAc [20] through activation of TrkB [60].
We suggest that perhaps in the face of chronic stress this mechanism is
disrupted and potentially reversed. Previous studies have shown that
CORT treatment in rats enhances dopamine release in the NAc [61]. In
addition, high stress-reactive mice show increased expression of DR2
in the nucleus accumbens [62]. Our results suggest that the mechanism
bywhich chronic CORT treatment up-regulates DR2 and DR3 expression
may be via long-term alterations to BDNF-TrkB signalling.
We have previously investigated behavioural changes in a compara-
ble ‘two hit’ ratmodel and observed an altered dopaminergic regulation
of prepulse inhibition (PPI) inmale rats. Therefore it is tempting to spec-
ulate that the altered expression proﬁle of BDNF, DR2 and DR3 in male
two-hit rats shown in the current study may, at least in part, explain
the previously found altered PPI response to dopamine receptor stimu-
lation by apomorphine and amphetamine [34]. Our previous studies
reported no signiﬁcant effect of either ‘hits’ on DR1 or DR2 receptorexpression in the CPu or NAc using receptor autoradiography [34]. Our
current study supports and extends this ﬁnding in that we found no sig-
niﬁcant changes in DR2 receptor expression in the CPu or NAc. Howev-
er, we did ﬁnd a signiﬁcant effect of CORT treatment on DR3 expression
in the NAc, as well as a signiﬁcant two-hit effect on both DR2 and DR3
expression in the mPFC.
It is important to note that themajority of BDNF in theNAc is derived
from the ventral tegmental area (VTA). A recent study by Walsh et al.
[63] demonstrated that BDNF expression in the NAc was up-regulated
following phasic optogenetic stimulation of the VTA-NAc pathway, in
socially stressed, but not stress-naïve mice. This stress-dependent up-
regulation of BDNF was mediated via corticotrophin releasing factor
(CRF), which, if blocked using a CRF receptor antagonist, prevented
BDNF up-regulation [63]. While Walsh et al. found that social stress
alone had no effect on BDNF expression, our results in the NAc show
that chronic CORT treatment during adolescence caused a long-lasting
reduction in BDNF expression in the NAc. Given the role of CRF in medi-
ating stress-induced alterations in BDNF expression in the NAc, future
studies should examine the effects of CRF receptor antagonist treatment
in our two-hit rat model. Behaviourally, Walsh et al. showed reduced
social interaction in socially-stressed, but not stress-naive VTA-NAc
stimulated animals [63]. Therefore social behaviour would also be of
interest in future two-hit rat model studies.
In summary, we report that the combined effect of two stressors
during critical periods of brain development causes a signiﬁcant, long-
lasting up-regulation of BDNF mRNA and protein levels in the mPFC of
male, but not female rats, and this correlated signiﬁcantly with an up-
regulation of DR3 mRNA expression. In addition, we show here that
chronic CORT treatment reduces BDNF mRNA expression in the NAc,
but up-regulates DR3 expression in the NAc of male rats. This is in
contrast to normal development, whereby BDNF is known to promote
DR3 expression. These data provide further insight into the impact of
stress at critical time periods of brain development.Acknowledgements
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